India's Central Drugs Standard Control Organization (CDSCO) is the national regulatory authority responsible for approving, monitoring, and regulating pharmaceutical products in the country. For international buyers seeking high-quality generic medicines…
The long-anticipated US-India bilateral trade deal is moving toward finalization, with major implications for India's generic pharmaceutical industry. US President Donald Trump confirmed at the G7 summit in Évian, France…
India, often called the "Pharmacy of the World," supplies over 20% of the global market for generic medicines and exports pharmaceutical products to more than 200 countries. However, for international…
The Indian pharmaceutical sector is undergoing a significant transformation in 2026, driven by landmark regulatory reforms from the Central Drugs Standard Control Organization (CDSCO), new clinical trial fast-track rules, updated…